Obesity Clinical Trial
— TOPS at DOCOfficial title:
Pilot Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic
Verified date | February 2020 |
Source | Duke University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this pilot proposal are the following: 1) to determine the feasibility and
acceptability of integrating the TOPS weight loss program into underserved populations
through an urban safety net clinic and 2) to gather preliminary data of weight change to
inform the design of a future randomized, controlled trial to determine the efficacy of the
TOPS program in safety net clinics.
To achieve these goals, the investigators will pursue the following Specific Aims:
Specific Aim 1. Assess the feasibility and acceptability of integrating the TOPS program into
an urban safety net clinic, with process measures (i.e., recruitment/refusal rates and
retention/dropout rates) and focus groups.
Hypothesis 1. Integrating the TOPS program into an urban safety net clinic is feasible and
acceptable to participants.
Specific Aim 2. Assess the percent of participants in the TOPS intervention arm with
clinically significant weight change (i.e., weight loss of ≥5% of initial body weight) at 12,
26, and 52 weeks.
Hypothesis 2. 10%, 25%, and 33% of participants in the TOPS intervention arm will lose ≥5% of
initial body weight at 12, 26, and 52 weeks, respectively.
Status | Completed |
Enrollment | 26 |
Est. completion date | December 5, 2019 |
Est. primary completion date | December 5, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Participants must be patients of the DOC. - BMI: Asian patients with a BMI of =23 kg/m2 and patients of other racial and ethnic backgrounds will be included if have a BMI of =25 kg/m2. Asian patients are allowed to participate at a BMI in the normal range because they are more likely to develop diabetes (or insulin resistance or glucose intolerance at a BMI of 23 kg/m2). Exclusion Criteria: - Mental illness that would cause disruptions to group meetings - Cognitive impairment that would preclude participants from understanding the program - Type 2 diabetics on insulin or sulfonylureas without provider approval - untreated hyper- or hypothyroidism - current cancer diagnosis - history of cancer (other than skin cancer) - gastrointestinal disorders affecting food intake - use of medications thought to effect metabolism, body weight, energy expenditure, or appetite - women currently pregnant or lactating, planning to become pregnant, or less than 6 months post-partum - weight loss of > 5% in past 6 months - major psychiatric disorder - current moderate to severe symptoms of depression - eating disorders - current alcohol or substance abuse. |
Country | Name | City | State |
---|---|---|---|
United States | Duke General Internal Medicine | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Duke University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Weight | Weekly weight data will be collected by the DOC Designee at baseline, 12, 24, and 52 weeks. | Baseline, 12, 24, and 52 weeks | |
Secondary | Program Attendance | Calculate the percentage of TOPS at DOC group session attendance (sessions attended/total offered). | 52 Weeks | |
Secondary | Retention as measured by attendance sheets | Calculate the retention of participants in the TOPS at DOC program at 12, 24, and 52 weeks. | 12, 24 and 52 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |